Adial Pharmaceuticals, Inc ADIL
$3.98
-17.08%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-7,770,762
- Net Margin
- —
- Return on Equity
- -209.05%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 2.34
- Price / Sales
- —
Over the trailing twelve months, Adial Pharmaceuticals, Inc generated revenue of — and net income of $-7,770,762.
Key Stats
- Last Close
- $3.98
- Market Cap
- $8.71 million
- 52-Week Range
- $1.31 – $18.90
- Average Volume
- 58K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.